More medical news from Wall Street Journal
Medtronic Revenue Continues to Grow on Acquisition
Wall Street Journal : May 31, 2016, 6:26 am
Medtronic gave a rosy revenue outlook for the year and reported better-than-expected growth in its fourth quarter, helped by its acquisition of Covidien.
Icahn Takes Big Stake in Allergan, Endorses Drugmaker's CEO
Wall Street Journal : May 31, 2016, 5:41 am
Billionaire investor Carl Icahn took a stake in Allergan PLC and threw his support behind the drug company’s chief executive, Brent Saunders, in a departure from the activist’s usual playbook.
FDA Rejects Teva's Application For Huntington's Drug
Wall Street Journal : May 31, 2016, 4:45 am
The Food and Drug Administration rejected a drug application from Teva Pharmaceutical Industries Ltd., asking for more information on the effects of the drug that treats some symptoms of Huntington’s disease.
BioMarin to Stop Developing Kyndrisa
Wall Street Journal : May 31, 2016, 3:22 am
BioMarin Pharmaceutical Inc. will abandon development of an experimental treatment for Duchenne muscular dystrophy and three other related products.
Jazz Pharmaceuticals Nears Deal to Buy Celator for About $1.5 Billion
Wall Street Journal : May 30, 2016, 8:59 am
Jazz Pharmaceuticals is nearing a deal to buy Celator Pharmaceuticals for about $1.5 billion, a huge premium for a company with a promising leukemia drug but no revenue.